Adient Price Target Cut to $31.00/Share From $32.00 by JP Morgan
Adient Is Maintained at Neutral by JP Morgan
BofA Securities Maintains Adient(ADNT.US) With Buy Rating
Express News | Adient PLC : BofA Global Research Cuts Price Objective to $40 From $42
Bank of America Securities Remains a Buy on Adient (ADNT)
J.P. Morgan Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $31
Express News | Adient PLC : JP Morgan Cuts Target Price to $31 From $32
Returns At Adient (NYSE:ADNT) Are On The Way Up
Barclays Adjusts Adient Price Target to $29 From $34, Maintains Equal Weight Rating
Adient Is Maintained at Equal-Weight by Barclays
Adient to Discuss Q3 Fiscal 2024 Financial Results on August 6, 2024
Barclays Maintains Adient(ADNT.US) With Hold Rating, Cuts Target Price to $29
Express News | Adient PLC : Barclays Cuts Target Price to $29 From $34
Adient Is Maintained at Neutral by UBS
Adient Price Target Cut to $27.00/Share From $31.00 by UBS
UBS Cuts Adient's Price Target to $27 From $31, Neutral Rating Maintained
Express News | Adient PLC : UBS Cuts Target Price to $27 From $31
Adient Raised to Neutral From Underperform by Exane BNP Paribas
Express News | Exane BNP Paribas Upgrades Adient to Neutral, Announces $26 Price Target
BNP Paribas Upgrades Adient(ADNT.US) to Hold Rating, Announces Target Price $26